Story
Airbus on Track to Meet 870-Aircraft Delivery Goal for 2026, CEO Says

Summary
Airbus CEO Guillaume Faury confirmed the company is on course for its full-year delivery target of 870 aircraft, citing a 15% increase in first-half deliveries and stabilizing engine supplies.
Airbus is on course to meet its full-year delivery target of 870 aircraft, according to CEO Guillaume Faury, who cited a significant increase in first-half output and an easing of supply chain pressures.
H1 Deliveries Bolster Outlook
Speaking with CNBC TV at the Farnborough Airshow, Faury confirmed that the European planemaker's performance in the first six months of the year supports its annual guidance. The comments were reported by Reuters.
"We have delivered 15% more aircraft in the first half of 2026 than we did in the first half of 2025," Faury stated. He described this performance as "very consistent with the ramp-up trajectory we want to deliver this year."
AdSupply Chain Stabilization
The CEO's confidence is partly based on the stabilization of engine supplies, a critical component that has created significant production bottlenecks for the aerospace industry since the pandemic. A more predictable flow of engines is essential for Airbus to maintain its assembly line speeds and work through its extensive order backlog.
For investors, consistent aircraft deliveries are a key performance metric, as revenue is typically recognized when an aircraft is handed over to a customer. Achieving the full-year target would signal a successful navigation of the persistent supply chain challenges that have affected the sector.
Read next
More on Stocks
Celanese Shares Surge After Announcing Broad Price Increases for Acetyl Products
The specialty materials company announced immediate price hikes for its core acetyl chain products across the Americas and EMEA, fueling investor optimism for margin recovery.

SB Energy Reaffirms Nasdaq IPO Plans, Refutes Delay Reports
SB Energy's multi-billion-dollar IPO is proceeding as planned, a source familiar with the matter said, pushing back on reports of a delay as the company secures major backing from tech giants like Nvidia and OpenAI.

Telix Pharma Shares Rebound on Analyst Upgrade, R&D Day After Acquisition Sell-off
The radiopharmaceutical company's stock is recovering from a steep drop triggered by a dilutive acquisition, bolstered by a positive analyst rating and a strategic pipeline update for investors.

Brinker International Stock Jumps on Analyst Upgrade and Bullish Outlook
Shares of the casual dining operator surged after Northcoast Research upgraded the stock to Buy, citing an attractive entry point following a recent pullback. Renewed confidence was also bolstered by a positive outlook from KeyBanc and a new institutional investment.